Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNC001157

Drug Information
NamePS-341
IndicationNot AvailableExperimental    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7
-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1
-2H3,(H,23,26)(H,24,25)/t15-,17-/m1/s1
InChIKeyGXJABQQUPOEUTA-NVXWUHKLSA-N
Canonical SMILESB(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O    
Isomeric SMILESB([C@@H](CC(C)C)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
CAS NumberCAS 179324-69-7
PubChem Compound IDCID 93860.
PubChem Substance IDSID 670916.
ChEBI52717;
SuperDrug ATC IDL01XX32
SuperDrug CAS ID179324697;
Target20S proteasomeInhibitor[1]
Nuclear factor NF-kappa-BInhibitor[2]
Ref 1Selected novel anticancer treatments targeting cell signaling proteins. Oncologist. 2001;6(6):517-37. To Reference
Ref 2Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications. Blood. 2002 Jun 1;99(11):4079-86. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543